Ch R Meier

Summary

Affiliation: University of Basel
Country: Switzerland

Publications

  1. ncbi request reprint Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
    C R Meier
    Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, Mass, USA
    Arch Intern Med 160:349-53. 2000
  2. ncbi request reprint Association between body mass index and liver disorders: an epidemiological study
    Christoph R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    J Hepatol 37:741-7. 2002
  3. ncbi request reprint Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer
    Christoph R Meier
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Pharmacotherapy 22:303-9. 2002
  4. pmc Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, University Hospital, Basel, Switzerland
    Br J Clin Pharmacol 52:179-84. 2001
  5. ncbi request reprint Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom
    C R Meier
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    Eur J Clin Microbiol Infect Dis 19:834-42. 2000
  6. ncbi request reprint HMG-CoA reductase inhibitors and the risk of fractures
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, University Hospital of Basel, Petersgraben 4, CH 4031, Basel, Switzerland
    JAMA 283:3205-10. 2000
  7. ncbi request reprint Antibiotics in the prevention and treatment of coronary heart disease
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, Dept of Internal Medicine, University Hospital, 4031 Basel, Switzerland
    J Infect Dis 181:S558-62. 2000
  8. ncbi request reprint [Is it possible to do pharmaco-epidemiological research using electronic databanks in the Swiss health care system?]
    Ch R Meier
    Basel Pharmacoepidemiology Unit, Abteilung Klinische Pharmakologie und Toxikologie Departement Innere Medizin Kantonsspital Basel 4031 Basel
    Praxis (Bern 1994) 92:997-1000. 2003
  9. ncbi request reprint Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin
    Christiane Gasse
    Department of Internal MedicineVI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Germany
    Thromb Haemost 94:537-43. 2005
  10. ncbi request reprint Migraine and the risk of stroke, TIA, or death in the UK (CME)
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Headache 47:1374-84. 2007

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
    C R Meier
    Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, Mass, USA
    Arch Intern Med 160:349-53. 2000
    ....
  2. ncbi request reprint Association between body mass index and liver disorders: an epidemiological study
    Christoph R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
    J Hepatol 37:741-7. 2002
    ..Cross-sectional studies showed an association between obesity and liver disorders. Information on incidence rates from epidemiological studies is scarce...
  3. ncbi request reprint Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer
    Christoph R Meier
    Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Pharmacotherapy 22:303-9. 2002
    ..To explore the association between exposure to acetaminophen (paracetamol) or nonsteroidal antiinflammatory drugs (NSAIDs) and risk of developing ovarian, breast, or colon cancer...
  4. pmc Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, University Hospital, Basel, Switzerland
    Br J Clin Pharmacol 52:179-84. 2001
    ....
  5. ncbi request reprint Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom
    C R Meier
    Department of Internal Medicine, University Hospital, Basel, Switzerland
    Eur J Clin Microbiol Infect Dis 19:834-42. 2000
    ..This analysis may lead to further analyses on the economic impact of influenza and the contribution of different population groups to that burden...
  6. ncbi request reprint HMG-CoA reductase inhibitors and the risk of fractures
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, University Hospital of Basel, Petersgraben 4, CH 4031, Basel, Switzerland
    JAMA 283:3205-10. 2000
    ..It is unknown whether use of statins is associated with a decreased risk of fractures in humans...
  7. ncbi request reprint Antibiotics in the prevention and treatment of coronary heart disease
    C R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology, Dept of Internal Medicine, University Hospital, 4031 Basel, Switzerland
    J Infect Dis 181:S558-62. 2000
    ..This review of published studies briefly summarizes the currently available literature on the effects of antibiotics on the risk of developing coronary heart disease and myocardial infarction...
  8. ncbi request reprint [Is it possible to do pharmaco-epidemiological research using electronic databanks in the Swiss health care system?]
    Ch R Meier
    Basel Pharmacoepidemiology Unit, Abteilung Klinische Pharmakologie und Toxikologie Departement Innere Medizin Kantonsspital Basel 4031 Basel
    Praxis (Bern 1994) 92:997-1000. 2003
  9. ncbi request reprint Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin
    Christiane Gasse
    Department of Internal MedicineVI, Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Germany
    Thromb Haemost 94:537-43. 2005
    ..warfarin alone was 4.5 (95% CI: 1.1-18.1). We conclude that concurrent use of potentially interacting drugs with warfarin is associated with a 3 to 4.5-fold increased risk of serious bleeding in long-term warfarin users...
  10. ncbi request reprint Migraine and the risk of stroke, TIA, or death in the UK (CME)
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland
    Headache 47:1374-84. 2007
    ..Previous observational studies have reported a higher risk of stroke in migraine patients. Objective.- We aimed to estimate the risk of stroke, transient ischemic attack (TIA), or death in migraineurs in the UK...
  11. ncbi request reprint Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Drug Saf 31:399-407. 2008
    ..Paradoxically, however, statins may have potentially beneficial effects on neurodegenerative diseases due to their anti-inflammatory properties...
  12. doi request reprint Use of thiazolidinediones and fracture risk
    Christian Meier
    Division of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital Basel, Hebelstrasse 2, CH 4031 Basel, Switzerland
    Arch Intern Med 168:820-5. 2008
    ..Thiazolidinediones may adversely affect the skeleton owing to decreased bone formation and accelerated bone loss...
  13. ncbi request reprint Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction
    Raymond G Schlienger
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Drug Saf 27:1157-65. 2004
    ..Selective serotonin reuptake inhibitors (SSRIs) may attenuate platelet activation by serotonin depletion in platelets. Observational studies have shown discrepant results of AMI risk associated with the use of SSRIs...
  14. ncbi request reprint Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction
    Lorenz M Fischer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Am J Cardiol 93:198-200. 2004
    ..23 to 1.76), and in subjects with both RA and diagnosed hyperlipidemia, the OR was 7.12 (95% CI 4.16 to 12.18). The risk associated with SLE was 2.67 (95% CI 1.34 to 5.34). These results underline that RA and SLE increase the risk of AMI...
  15. ncbi request reprint Inhaled corticosteroids and the risk of fractures in children and adolescents
    Raymond G Schlienger
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    Pediatrics 114:469-73. 2004
    ..To determine whether children or adolescents who are exposed to inhaled corticosteroids (ie, beclomethasone, budesonide, fluticasone) are at a higher risk of having bone fractures compared with nonexposed individuals...
  16. pmc Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction
    Raymond G Schlienger
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    Br J Clin Pharmacol 54:327-32. 2002
    ..We compared use of NSAIDs prior to the index date between cases and control patients who were matched to cases on age, gender, practice and calendar time...
  17. ncbi request reprint Validity of the general practice research database
    Susan S Jick
    Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, Massachusetts 02421, USA
    Pharmacotherapy 23:686-9. 2003
    ..We reviewed evidence related to the validity of the GPRD. Specifically, with our extensive experience with this automated database, we evaluated the quality and completeness of the data that it contains...
  18. doi request reprint Use of antihypertensives and the risk of Parkinson disease
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Hebelstrasse 2, CH 4031 Basel, Switzerland
    Neurology 70:1438-44. 2008
    ..Recent studies related angiotensin converting enzyme (ACE) inhibitors and calcium channel blockers to possible neuroprotective effects. Little is known about neuroprotection of angiotensin II (AT II) antagonists or beta-blockers...
  19. ncbi request reprint Risk factors for gastrointestinal bleeding: a hospital-based case-control study
    Priska Vonbach
    Hospital Pharmacy, Kantonsspital Winterthur University Children s Hospital Zurich, Switzerland
    Swiss Med Wkly 137:705-10. 2007
    ..We investigated risk factors for a first-time GI bleeding leading to hospital admission with a focus on drugs and drug-drug interactions (DDIs)...
  20. doi request reprint Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study
    Yolanda B Brauchli
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    J Am Acad Dermatol 58:421-9. 2008
    ..Small clinical trials suggest that thiazolidinediones may exert a beneficial effect on skin lesions of patients with psoriasis. Little is known about other classes of antidiabetic drugs and the psoriasis risk...
  21. doi request reprint The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Headache 48:606-10. 2008
    ..Previous observational studies reported an increased prevalence of asthma in migraine patients. Whether triptans affect the asthma risk has not yet been explored in an epidemiological study...
  22. ncbi request reprint Use of beta-blockers and risk of fractures
    Raymond G Schlienger
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    JAMA 292:1326-32. 2004
    ....
  23. ncbi request reprint Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies
    Sylvie Petitjean
    Division of Substance Use Disorders, University Psychiatric Clinics Basel, Wilhelm Klein Strasse 27, CH 4025 Basel, Switzerland
    Int Clin Psychopharmacol 22:292-8. 2007
    ..The purpose of the study was to assess prevalence of benzodiazepine use in the Swiss adult population and to assess on benzodiazepine prescription patterns of physicians in domiciliary practice...
  24. ncbi request reprint Statins and the risk of pneumonia: a population-based, nested case-control study
    Raymond G Schlienger
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Pharmacotherapy 27:325-32. 2007
    ..To determine if the use of statins affects pneumonia-related outpatient visits, hospitalizations with survival, and deaths...
  25. ncbi request reprint Commentary: statins and fracture risk--unresolved questions
    Christoph R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Hebelstrasse 2, 4031 Basel, Switzerland
    Int J Epidemiol 35:1308-9. 2006
  26. ncbi request reprint The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials
    Christoph R Meier
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Drug Saf 27:203-13. 2004
    ....
  27. ncbi request reprint Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction
    Lorenz M Fischer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    Pharmacotherapy 25:503-10. 2005
    ..To evaluate the risk of acute myocardial infarction during current exposure to nonsteroidal antiinflammatory drugs (NSAIDs)...
  28. ncbi request reprint Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction
    Lorenz M Fischer
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
    Arch Intern Med 164:2472-6. 2004
    ..However, the effect of the use of nonsteroidal anti-inflammatory drugs (NSAIDs) on the risk of AMI has not yet been well defined. We therefore studied the risk of AMI during NSAID exposure and after the cessation of NSAID therapy...
  29. pmc Diabetes in patients with idiopathic Parkinson's disease
    Claudia Becker
    Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland
    Diabetes Care 31:1808-12. 2008
    ..We aimed at comparing the diabetes prevalence between patients with or without Parkinson's disease and at exploring the risk of developing incident diabetes associated with Parkinson's disease...